Chief Scientific Officer
Patrick Maurel spent 40 years in academia culminating as research director at Inserm. Patrick is world expert in the field of hepatology and has had a pivotal role in the development of primary cultures of human hepatocytes as screening tools used within the pharmaceutical industry. More recently, Patrick\'s research has been focused on the mechanisms of hepatitis C infection and on the use of stem cells as a potential biotherapy of liver diseases. Patrick has co-authored more than 180 international publications and is a fellow of several learned societies related to drug industries, drug metabolism, virology and hepatology.
drug metabolism, virology and hepatology.